You have 9 free searches left this month | for more free features.

medi4736

Showing 1 - 25 of 29

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic, Melanoma, Non Small Cell Lung Cancer (NSCLC) Trial in Philadelphia (Radiotherapy, MEDI4736, Tremelimumab)

Active, not recruiting
  • Metastatic
  • +4 more
  • Radiotherapy
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jan 6, 2023

Renal Clear Cell Carcinoma, Renal Papillary Cell Carcinoma Trial in London (Savolitinib, MEDI4736, Tremelimumab)

Active, not recruiting
  • Renal Clear Cell Carcinoma
  • Renal Papillary Cell Carcinoma
  • London, United Kingdom
    Thomas Powles
Aug 10, 2022

Advanced Solid Tumours Trial in Denver, Sarasota, Nashville (AZD1775, MEDI4736)

Active, not recruiting
  • Advanced Solid Tumours
  • Denver, Colorado
  • +2 more
Aug 18, 2022

Mesothelioma Trial in Houston (MEDI4736, Tremelimumab, no other name)

Active, not recruiting
  • Mesothelioma
  • MEDI4736
  • +2 more
  • Houston, Texas
    Baylor St Lukes
Jan 25, 2022

NSCLC Trial in Japan, Korea, Republic of, United States (Gefitinib, MEDI4736)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Tampa, Florida
  • +6 more
Mar 22, 2022

Solid Tumors, Head Neck Cancer, Lung Cancer Trial in United States (MEDI4736, INCB024360)

Completed
  • Solid Tumors
  • +3 more
  • San Francisco, California
  • +12 more
Jan 7, 2022

Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (AZD9150, MEDI4736, AZD5069)

Active, not recruiting
  • Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck
  • Birmingham, Alabama
  • +42 more
Oct 3, 2022

Advanced Colorectal Cancer Trial in New York (MEDI4736)

Completed
  • Advanced Colorectal Cancer
  • MEDI4736
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 25, 2021

Triple Negative Breast Cancer Trial in Belgium, France (Paclitaxel, Carboplatin, MEDI4736)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Brussels, Belgium
  • +17 more
Feb 28, 2022

Advanced Solid Tumors Trial in Japan, Korea, Republic of, Taiwan (MEDI4736, tremelimumab)

Completed
  • Advanced Solid Tumors
  • Beppu-shi, Japan
  • +20 more
Mar 11, 2021

NSCLC Trial in Worldwide (MEDI4736)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • MEDI4736
  • Goodyear, Arizona
  • +137 more
Jan 23, 2023

Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)

Active, not recruiting
  • Muscle Invasive Bladder Cancer
  • Los Angeles, California
  • +26 more
Oct 17, 2022

NSCLC Trial in Worldwide (MEDI4736, PLACEBO)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • MEDI4736
  • PLACEBO
  • Chandler, Arizona
  • +235 more
Jan 4, 2023

Advanced Solid Tumors Trial in Worldwide (MEDI4736)

Completed
  • Advanced Solid Tumors
  • MEDI4736
  • Scottsdale, Arizona
  • +78 more
Apr 20, 2021

Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)

Active, not recruiting
  • Metastatic Breast Cancer
  • Angers, France
  • +24 more
Mar 8, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (MEDI4736, Tremelimumab, MEDI4736+Tremelimumab)

Completed
  • Squamous Cell Carcinoma of the Head and Neck
  • MEDI4736
  • +6 more
  • Aurora, Colorado
  • +196 more
Sep 16, 2021

Recurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHN Trial in Worldwide

Completed
  • Recurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHN
  • MEDI4736
  • +2 more
  • Tucson, Arizona
  • +168 more
Jan 21, 2021

Cervical Cancer, Cancer, Head Neck Cancer Trial in United States (ADXS11-001, Medi4736)

Unknown status
  • Cervical Cancer
  • +2 more
  • Los Angeles, California
  • +16 more
Feb 18, 2020

Recurrent/Metastatic Squamous Cell Carcinoma of Head & Neck Trial in Worldwide (MEDI4736, Tremelimumab, MEDI4736 + Tremelimumab)

Completed
  • Recurrent/Metastatic Squamous Cell Carcinoma of Head & Neck
  • MEDI4736
  • +2 more
  • Birmingham, Alabama
  • +124 more
Sep 11, 2020

NSCLC Trial in Worldwide (MEDI4736, Placebo)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • MEDI4736
  • Placebo
  • Gilbert, Arizona
  • +270 more
Mar 2, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, NSCLC Trial in Worldwide (Ramucirumab, MEDI4736)

Completed
  • Gastric Cancer
  • +3 more
  • Santa Monica, California
  • +27 more
Jan 18, 2021

Adenocarcinoma of the Oesophagus, Adenocarcinoma of the Gastro-oesophageal Junction, Adenocarcinoma of the Stomach Trial in

Recruiting
  • Adenocarcinoma of the Oesophagus
  • +2 more
  • Sutton, United Kingdom
    The Royal Marsden NHS Foundation Trust, Downs Road, Sutton
Feb 19, 2020

DLBCL, Follicular Lymphoma Trial in United States (Ibrutinib, MEDI4736)

Completed
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • Birmingham, Alabama
  • +10 more
Jun 3, 2019

NSCLC, NSCLC, Lung Cancer Trial in Worldwide (MEDI4736, Tremelimumab, tremelimumab)

Completed
  • NSCLC
  • +2 more
  • MEDI4736
  • +2 more
  • Birmingham, Alabama
  • +68 more
Oct 29, 2019